Malignant Endocrine Neoplasm — Trials

Malignant Endocrine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,801 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 576
Recruiting: 291
Ph III recruiting: 33
Growth YoY: +0.7%
Industry share: 34%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (238)

clinicaltrialsPublishedShowing 351–365 of 365 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06277180	68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC	recruiting	N/A	50	Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER	1	Feb 26, 2024	clinicaltrials
NCT06255197	Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers	recruiting	—	60,000	Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER	1	Feb 16, 2024